Cancer (Oncology)

Checkpoint inhibitors are focus at ESMO

Read more

Microbiome-based therapies as anti-cancer agents

Read more

Antibody-drug conjugates come to the fore

Read more

The microbiome and cancer

Read more

ASCO delivers new cancer data - and one surprise

Read more

Targeting the innate immune system in cancer

Read more

Cell therapy shows promise in pancreatic cancer

Read more

Cancer Research UK has new model

Read more

Global regulators approve new cancer therapies

Read more

Triple Negative Breast Cancer: A subtractive approach to treatment

Read more